Drug name - Suboxone

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10285910 INDIVIOR INC Sublingual and buccal film compositions Oct, 2022

(8 days from now)

US8017150 INDIVIOR INC Polyethylene oxide-based films and drug delivery systems made therefrom Feb, 2023

(4 months from now)

US8603514 INDIVIOR INC Uniform films for rapid dissolve dosage form incorporating taste-masking compositions Apr, 2024

(1 year, 6 months from now)

US9687454 INDIVIOR INC Sublingual and buccal film compositions Aug, 2029

(6 years from now)

US11135216 INDIVIOR INC Sublingual and buccal film compositions Aug, 2029

(6 years from now)

US8475832 INDIVIOR INC Sublingual and buccal film compositions Mar, 2030

(7 years from now)

Drugs and Companies using BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE ingredient

Treatment: Treatment of opioid dependence/sublingual or buccal application; Treating opioid use disorder; This drug is administered by sublingual route to humans for maintenance treatment of opioid dependence

Dosage: FILM;BUCCAL, SUBLINGUAL

More Information on Dosage
Strength Dosage Availability
EQ 2MG BASE;EQ 0.5MG BASE FILM;BUCCAL, SUBLINGUAL Prescription
EQ 4MG BASE;EQ 1MG BASE FILM;BUCCAL, SUBLINGUAL Prescription
EQ 8MG BASE;EQ 2MG BASE FILM;BUCCAL, SUBLINGUAL Prescription
EQ 12MG BASE;EQ 3MG BASE FILM;BUCCAL, SUBLINGUAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.